Rolando E. Mendez - Concepedia

Author

Rolando E. Mendez

University of Virginia Health System ORCID

Also Known As

Rolando E Mendez, Rolando E. Mendez, Rolando MEndez, Rolando Mendez

Publications

211

Citations

H-Index

Concepts

All Affiliations

University of Virginia Health System Virginia Commonwealth University University of Virginia

About

Rolando E. Mendez is an author at University of Virginia Health System specializing in tumor microenvironment, tumor biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	28
2	Cell Biology	2	2	28
3	Pathology	2	2	28
4	Pharmacology	1	1	11
5	Cancer Therapeutics	1	1	11

Rolando E. Mendez

Publications

138

Citations

H-Index

Page 1

	Year	Citations
MASSIVE SATELLITES OF CLOSE-IN GAS GIANT EXOPLANETS Timothy A. Cassidy, Rolando E. Mendez, Phil Arras, The Astrophysical Journal Exoplanet AtmosphereExoplanet FormationOuter PlanetExtrasolar SystemTidal Heating	2009	47
PRAS40 Phosphorylation Correlates with Insulin-Like Growth Factor-1 Receptor-Induced Resistance to Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells Michael I. Dougherty, Christine E. Lehman, Adam Spencer, Molecular Cancer Research PathologyMtorc1 InhibitorCancer BiologyTumor BiologyPras40 Phosphorylation	2020	17
Design, Synthesis, and Biological Evaluation of NAP Isosteres: A Switch from Peripheral to Central Nervous System Acting Mu-Opioid Receptor Antagonists Piyusha P. Pagare, Mengchu Li, Yi Zheng, Journal of Medicinal Chemistry	2022	17
Activation of the insulin‐like growth factor‐1 receptor alters p27 regulation by the epidermal growth factor receptor in oral squamous carcinoma cells Mark J. Jameson, Linnea E. Taniguchi, Kyle K. VanKoevering, Journal of Oral Pathology and Medicine	2012	15
Effect of Adipose‐Derived Stem Cells on Head and Neck Squamous Cell Carcinoma Deepa Danan, Christine E. Lehman, Rolando E. Mendez, Otolaryngology	2018	11
Survivin in Insulin-Like Growth Factor-Induced Resistance to Lapatinib in Head and Neck Squamous Carcinoma Cells Christine E. Lehman, Rolando E. Mendez, Michael I. Dougherty, Frontiers in Oncology Lapatinib SensitivityChemoprevention StrategyIgf1r ActivationPathologyCancer Biology	2019	11
Characterization of a Potential KOR/DOR Dual Agonist with No Apparent Abuse Liability via a Complementary Structure–Activity Relationship Study on Nalfurafine Analogues Mengchu Li, David L. Stevens, Michelle Arriaga, ACS Chemical Neuroscience	2022	10
Structural Alterations of the “Address” Moiety of NAN Leading to the Discovery of a Novel Opioid Receptor Modulator with Reduced hERG Toxicity Hongguang Ma, Piyusha P. Pagare, Mengchu Li, Journal of Medicinal Chemistry	2022	10

Page 1